Yang Ho Park

432 total citations
16 papers, 381 citations indexed

About

Yang Ho Park is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yang Ho Park has authored 16 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yang Ho Park's work include Cancer Mechanisms and Therapy (5 papers), Cancer Cells and Metastasis (5 papers) and Flavonoids in Medical Research (3 papers). Yang Ho Park is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Cancer Cells and Metastasis (5 papers) and Flavonoids in Medical Research (3 papers). Yang Ho Park collaborates with scholars based in South Korea, India and China. Yang Ho Park's co-authors include Mrinmoy Ghosh, Neelesh Sharma, Dong Kee Jeong, Nameun Kim, Amit Kumar Singh, Do Luong Huynh, Jiaojiao Zhang, Raj Kumar Mongre, Simrinder Singh Sodhi and Taeho Kwon and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Critical Reviews in Food Science and Nutrition and Materials Science and Engineering C.

In The Last Decade

Yang Ho Park

15 papers receiving 372 citations

Peers

Countries citing papers authored by Yang Ho Park

Since Specialization

Citations

This map shows the geographic impact of Yang Ho Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ho Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ho Park more than expected).

Fields of papers citing papers by Yang Ho Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Ho Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ho Park. The network helps show where Yang Ho Park may publish in the future.

Co-authorship network of co-authors of Yang Ho Park

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Ho Park. A scholar is included among the top collaborators of Yang Ho Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Ho Park. Yang Ho Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Anticancer Effect of ERM210 on Liver Cancer Cells Through ROS/Mitochondria-dependent Apoptosis Signaling Pathways 2021 ·In Vivo ·(unknown), (unknown), (unknown), (unknown), (unknown), Ji‐Hwan Kim, Yang Ho Park, Hu‐Nan Sun, Taeho Kwon	5
2	Anti-tumor Properties of Picrasma quassioides Extracts in H-Ras^G12V Liver Cancer Are Mediated Through ROS-dependent Mitochondrial Dysfunction 2020 ·Anticancer Research ·(unknown), (unknown), Yinghua Jin, Chenxi Ren, Yue Liu, Ying‐Hao Han, Meihua Jin, Dan Zhu, (unknown), Liyun Yu, Dong‐Seok Lee, (unknown), (unknown), Yang Ho Park, Jin Won Hyun, Taeho Kwon, Yudong Cui, Hu‐Nan Sun	12
3	BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2 2020 ·In Vivo ·Nisansala Chandimali, Hu‐Nan Sun, Yang Ho Park, Taeho Kwon	14
4	BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells 2018 ·Cell Death and Disease ·Taeho Kwon, Nisansala Chandimali, Do Luong Huynh, Jiaojiao Zhang, Nameun Kim, Yesol Bak, Do‐Young Yoon, Dae‐Yeul Yu, Jae Cheol Lee, Meeta Gera, Mrinmoy Ghosh, Yang Ho Park, Dong Kee Jeong	24
5	SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis 2018 ·Biochemical and Biophysical Research Communications ·Do Luong Huynh, Jiaojiao Zhang, Nisansala Chandimali, Mrinmoy Ghosh, Meeta Gera, Nameun Kim, Yang Ho Park, Taeho Kwon, (unknown)	15
6	The Novel Nutraceutical KJS018A Prevents Hepatocarcinogenesis Promoted by Inflammation 2018 ·Evidence-based Complementary and Alternative Medicine ·Do Luong Huynh, Nisansala Chandimali, Jiaojiao Zhang, Nameun Kim, Yang Ho Park, Taeho Kwon, Dong Kee Jeong	2
7	Synthesis and evaluation of the antiproliferative efficacy of BRM270 phytocomposite nanoparticles against human hepatoma cancer cell lines 2018 ·Materials Science and Engineering C ·Meeta Gera, Nameun Kim, Mrinmoy Ghosh, Neelesh Sharma, Do Luong Huynh, Nisansala Chandimali, (unknown), Jiaojiao Zhang, (unknown), Yang Ho Park, Taeho Kwon, Dong Kee Jeong	10
8	Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis , through regulating different signaling pathways 2017 ·Chinese Journal of Natural Medicines ·Do Luong Huynh, Neelesh Sharma, Amit Kumar Singh, Simrinder Singh Sodhi, Jiaojiao Zhang, Raj Kumar Mongre, Mrinmoy Ghosh, Nameun Kim, Yang Ho Park, Dong Kee Jeong	88
9	Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression 2017 ·BMC Complementary and Alternative Medicine ·Do Luong Huynh, Taeho Kwon, Jiaojiao Zhang, Neelesh Sharma, Meeta Gera, Mrinmoy Ghosh, Nameun Kim, Somi Kim Cho, Dong Sun Lee, Yang Ho Park, (unknown)	27
10	Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model 2017 ·Biomedicine & Pharmacotherapy ·Raj Kumar Mongre, Neelesh Sharma, Simrinder Singh Sodhi, Mrinmoy Ghosh, Amit Kumar Singh, Nameun Kim, Yang Ho Park, (unknown), Sung Jin Kim, Jiaojiao Zhang, Do Luong Huynh, Dong Kee Jeong	8
11	MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells 2017 ·Oncotarget ·(unknown), Hyeri Park, Nisansala Chandimali, Do Luong Huynh, Jiaojiao Zhang, Mrinmoy Ghosh, Meeta Gera, Nameun Kim, Yesol Bak, Do‐Young Yoon, Yang Ho Park, Taeho Kwon, Dong Kee Jeong	37
12	Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells 2016 ·Critical Reviews in Food Science and Nutrition ·Amit Kumar Singh, Neelesh Sharma, Mrinmoy Ghosh, Yang Ho Park, Dong Kee Jeong	70
13	The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells 2015 ·International Journal of Oncology ·Raj Kumar Mongre, Simrinder Singh Sodhi, Mrinmoy Ghosh, Jeong Hyun Kim, Nameun Kim, Yang Ho Park, Sung Jin Kim, (unknown), Neelesh Sharma, Dong Kee Jeong	32
14	Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma 2015 ·International Journal of Oncology ·Raj Kumar Mongre, Simrinder Singh Sodhi, Neelesh Sharma, Mrinmoy Ghosh, Jeong Hyun Kim, Nameun Kim, Yang Ho Park, (unknown), Sung Jin Kim, Jiaojiao Zhang, Do Luong Huynh, Dong Kee Jeong	30
15	Development of Estimating Method of Leaf Area for Non-destructive Diagnosis of Growth and Development of Tomato Plants 2015 ·(unknown), Yang Ho Park, (unknown), (unknown), (unknown), Jeong Hyun Lee	1
16	Changes of Ascorbic Acid and Nitrate Content in Lettuce by Unbalanced Nutrient Solution 2006 ·The Korean Journal of Crop Science ·Yang Ho Park, (unknown), Jae Hong Park, Ju Young Lee, (unknown), (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact